Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
US8252748B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2008 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | Feb 7, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a peptide derived from neurotensin receptor 3 (NTSR3), and to the use thereof in the treatment of psychiatric diseases. The present invention particularly relates to the use of this peptide for producing a drug, such as an antidepressant. The peptide of the invention is characterized in that the sequence thereof is the attached SEQ ID No. 2. The present invention can be used in the fields of the pharmaceutical industry and particularly in the field of drug development for treating psychiatric diseases. The present invention can also be used in the development of a novel antidepressant. It can also be used for example, in the treatment of pain and inflammations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.